Insider · CIK 0002074392
Accardi Mario Alberto
Reports to the SEC for 1 company · CHESHIRE
Transactions
30
Companies
1
Filings
7
CIK
0002074392
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-24 | Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer | — |
| 2026-06-24 | Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer | — |
| 2026-06-24 | Centessa Pharmaceuticals plcD Disposition to Issuer | — |
| 2026-06-24 | Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer | — |
| 2026-06-24 | Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer | — |
| 2026-06-24 | Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer | — |
| 2026-06-24 | Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer | — |
| 2026-05-01 | Centessa Pharmaceuticals plcF Tax Payment | −$23.8K |
| 2026-02-02 | Centessa Pharmaceuticals plcShare Option (right to buy)A Award | — |
| 2026-02-02 | Centessa Pharmaceuticals plcA Award | — |
| 2026-02-01 | Centessa Pharmaceuticals plcF Tax Payment | −$71.6K |
| 2025-12-09 | Centessa Pharmaceuticals plcS Sale | −$75K |
| 2025-12-09 | Centessa Pharmaceuticals plcS Sale | −$213K |
| 2025-12-08 | Centessa Pharmaceuticals plcM Exercise/Conversion | +$47.7K |
| 2025-12-08 | Centessa Pharmaceuticals plcS Sale | −$300K |
| 2025-12-08 | Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion | — |
| 2025-11-01 | Centessa Pharmaceuticals plcF Tax Payment | −$14.8K |
| 2025-10-27 | Centessa Pharmaceuticals plcS Sale | −$200K |
| 2025-10-27 | Centessa Pharmaceuticals plcM Exercise/Conversion | +$40.1K |
| 2025-10-27 | Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion | — |
| 2025-09-16 | Centessa Pharmaceuticals plcS Sale | −$16.3K |
| 2025-09-16 | Centessa Pharmaceuticals plcS Sale | −$159K |
| 2025-09-09 | Centessa Pharmaceuticals plcS Sale | −$140K |
| 2025-09-09 | Centessa Pharmaceuticals plcM Exercise/Conversion | +$40.1K |
| 2025-09-09 | Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion | — |
| 2025-08-01 | Centessa Pharmaceuticals plcF Tax Payment | −$10.3K |
| 2025-07-29 | Centessa Pharmaceuticals plcS Sale | −$127K |
| 2025-06-24 | Centessa Pharmaceuticals plcM Exercise/Conversion | +$57.8K |
| 2025-06-24 | Centessa Pharmaceuticals plcS Sale | −$210K |
| 2025-06-24 | Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion | — |
Recent filings
- 4Accardi Mario Alberto0001470831-26-000616SEC(opens sec.gov)
- 4Accardi Mario Alberto0001470831-26-000463SEC(opens sec.gov)
- 4Accardi Mario Alberto0001470831-26-000088SEC(opens sec.gov)
- 4Accardi Mario Alberto0001470831-25-000390SEC(opens sec.gov)
- 4Accardi Mario Alberto0001470831-25-000388SEC(opens sec.gov)
- 4Accardi Mario Alberto0001470831-25-000288SEC(opens sec.gov)
- 4Accardi Mario Alberto0001470831-25-000273SEC(opens sec.gov)
Companies
Address
C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM
CHESHIRE, WA14 2DT